. Author manuscript; available in PMC: 2021 Mar 25.

Published in final edited form as: Vet Pathol. 2018 May 22;55(5):622–633. doi: 10.1177/0300985818776054

Table 4.

Percentage of Cells With Immunolabeling for E-Cadherin (E-cad), Vimentin (Vim), and SNAIL/SLUG⁺ in Canine Mammary Carcinomas of Grades I, II, and III.^a

	Percentage of Cells (Median, Range)			Group Comparisons
Immunolabeling Pattern	Grade I (n = 4)	Grade II (n = 6)	Grade III (n = 10)	I vs II	I vs III	II vs III
E-Cad⁺Vim⁻ membranous	17.2 (0.0–72.4)	9.5 (0.3–16.4)	16.9 (0.0–57.4)	P > .99	P > .99	P > .99
E-Cad⁺Vim⁻ cytoplasmic	63.6 (20.4–94.6)	59.9 (2.8–78.2)	54.7 (9.1–87.6)	P > .99	P > .99	P > .99
E-Cad⁺Vim⁻ total	93.7 (66.5–95.0)	70.7 (9.5–89.6)	84.7 (20.6–98.2)	P = .19	P > .99	P = .63
E-Cad⁻Vim⁺	0.5 (0.0–1.8)	3.7 (0.4–62.6)	3.2 (0.6–37.2)	P = .07	P = .08	P > .99
E-Cad⁺Vim⁺ (cell count)	0.0 (0.0–2.8)	7.9 (2.2–28.4)	6.8 (0.6–12.5)	P = .03*	P = .04*	P > .99
E-Cad⁺Vim⁺ (area)	0.04 (0.003–2.3)	1.3 (0.6–4.1)	1.6 (0.8–2.7)	P = .45	P = .17	P > .99
SNAIL/SLUG⁺	45.0 (10.0–71.0)	8.5 (0.0–90.0)	42.5 (5.0–95.0)	P = .57	P > .99	P = .10

E-Cad⁺Vim⁺ cells were enumerated as in Table 3. Group comparisons via Kruskal-Wallis tests followed by Dunn’s multiple comparisons tests.